GeoVax Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress
May 14, 2019 10:23 ET
|
GeoVax, Inc.
ATLANTA, May 14, 2019 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVXD), a biotechnology company developing human vaccines, today announced its financial results for the three months ended March...
Update: GeoVax Announces Reverse Stock Split
May 03, 2019 09:16 ET
|
GeoVax, Inc.
1:500 Reverse Split Effective May 2, 2019;Ticker Symbol Changed to GOVXD for 20 Days ATLANTA, GA , May 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX) today...
GeoVax Announces Reverse Stock Split
May 03, 2019 08:59 ET
|
GeoVax, Inc.
1:500 Reverse Split Effective May 2, 2019;Ticker Symbol Changed to GOVXD for 20 Days ATLANTA, GA, May 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX) today...
GeoVax Provides Product Development and Corporate Update
March 11, 2019 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, March 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines and immunotherapies using its novel viral vector...
GeoVax and Leidos Expand Collaboration to Malaria Vaccines
March 04, 2019 09:00 ET
|
GeoVax, Inc.
Supported by Contract from U.S. Agency for International Development (USAID) ATLANTA, GA, March 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a...
GeoVax CEO David Dodd Responds to President Trump’s State of the Union Message
February 06, 2019 10:11 ET
|
GeoVax, Inc.
Applauding HIV Elimination Goals and Encouraging More Resources Toward Vaccine Development ATLANTA, GA, Feb. 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX)....
GeoVax and Enesi Pharma to Collaborate on Development of Multiple Vaccines Administered by ImplaVax®, a Novel Needle-Free Vaccine Delivery Platform
January 02, 2019 07:30 ET
|
GeoVax, Inc.
Potential for Addressing Multiple Infectious Disease Targets ATLANTA, GA and OXFORD, UK, Jan. 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a...
GeoVax Observes 2018 World AIDS Day
December 03, 2018 09:00 ET
|
GeoVax, Inc.
Recognizing the Importance of Partnerships ATLANTA, GA, Dec. 03, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE– GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines,...
GeoVax Provides Update on HIV Clinical Trials Program
November 28, 2018 09:00 ET
|
GeoVax, Inc.
Innovative Combination Vaccine Advancing in Clinical Trials ATLANTA, GA, Nov. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company...
GeoVax Reports 2018 Third Quarter Financial Results and Provides Corporate Update
November 08, 2018 12:18 ET
|
GeoVax, Inc.
ATLANTA, Nov. 08, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines using its novel viral vector platform technology, announced its...